Ignite Creation Date:
2024-05-05 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00557349
Status:
COMPLETED
Last Update Posted:
2017-01-19
First Post:
2007-11-12
Brief Title:
Ulcer Prevention Study in Post Gastric Bypass Patients
Sponsor:
University of Missouri-Columbia
Organization:
University of Missouri-Columbia
Study Overview
Official Title:
A Randomized Double-blind Clinical Trial Comparing Zegerid Capsule to Famotidine in Preventing Anastomotic Marginal Ulcers in Post Gastric Bypass Patients
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research is to determine which medication Zegerid OmeprazoleSodium Bicarbonate or Pepcid AC Famotidine works best at reducing the chance that a patient will get an ulcer after gastric bypass surgery
Detailed Description:
The purpose of this research is to evaluate information about the control of gastric acid in post gastric bypass surgery patients Goal is to determine which medication best reduces the incidence of anastomotic ulcers post-operatively
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None